Docteur ROSSIGNOL: what changed
Docteur ROSSIGNOL
Largest movements
- Cash +€297,722
up €297,722 (+29.8%), from €998,757 to €1.3m
mainly Net result for the year (+€155,968) and Current investments (+€140,619)
- Current investments -€140,619
down €140,619 (-73.8%), from €190,568 to €49,949
- Reserves +€155,968
up €155,968 (+13.2%), from €1.2m to €1.3m
of which Distributable reserves: +€155,968
- Financial charges +€19,779
up €19,779, from -€11,971 to €7,808
- Gross operating margin +€16,636
up €16,636 (+7.1%), from €233,395 to €250,031
- Financial income -€3,689
down €3,689 (-38.6%), from €9,547 to €5,858
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,237,987 | €1,391,578 | +€153,591 | +12.4% |
| Fixed assets | 21/28 | €45,449 | €33,699 | -€11,750 | -25.9% |
| Tangible fixed assets | 22/27 | €45,449 | €33,699 | -€11,750 | -25.9% |
| Furniture and vehicles | 24 | €22,904 | €18,806 | -€4,098 | -17.9% |
| Other tangible fixed assets | 26 | €22,545 | €14,892 | -€7,652 | -33.9% |
| Current assets | 29/58 | €1,192,539 | €1,357,879 | +€165,340 | +13.9% |
| Amounts receivable within one year | 40/41 | - | €131 | +€131 | |
| Other amounts receivable | 41 | - | €131 | +€131 | |
| Current investments | 50/53 | €190,568 | €49,949 | -€140,619 | -73.8% |
| Cash at bank and in hand | 54/58 | €998,757 | €1,296,479 | +€297,722 | +29.8% |
| Deferred charges and accrued income | 490/1 | €3,214 | €11,321 | +€8,107 | +252% |
| Total equity and liabilities | 10/49 | €1,237,987 | €1,391,578 | +€153,591 | +12.4% |
| Equity | 10/15 | €1,216,644 | €1,372,613 | +€155,968 | +12.8% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,185,430 | €1,341,398 | +€155,968 | +13.2% |
| Non-distributable reserves | 130/1 | €381,133 | €381,133 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Other | 1319 | €379,273 | €379,273 | = | 0.0% |
| Distributable reserves | 133 | €804,297 | €960,265 | +€155,968 | +19.4% |
| Profit (loss) carried forward | 14 | €18,814 | €18,814 | = | 0.0% |
| Amounts payable | 17/49 | €21,343 | €18,965 | -€2,378 | -11.1% |
| Amounts payable within one year | 42/48 | €21,343 | €18,965 | -€2,378 | -11.1% |
| Taxes, remuneration and social security | 45 | €14,736 | €18,965 | +€4,229 | +28.7% |
| Taxes | 450/3 | €14,736 | €18,965 | +€4,229 | +28.7% |
| Other amounts payable | 47/48 | €6,607 | - | -€6,607 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,526 | €16,042 | +€1,516 | +10.4% |
| Other operating charges | 640/8 | €763 | €415 | -€348 | -45.6% |
| Gross operating margin | 9900 | €233,395 | €250,031 | +€16,636 | +7.1% |
| Operating profit (loss) | 9901 | €218,107 | €233,574 | +€15,468 | +7.1% |
| Financial income | 75/76B | €9,547 | €5,858 | -€3,689 | -38.6% |
| Recurring financial income | 75 | €9,547 | €5,858 | -€3,689 | -38.6% |
| Financial charges | 65/66B | -€11,971 | €7,808 | +€19,779 | |
| Recurring financial charges | 65 | -€11,971 | €7,808 | +€19,779 | |
| Profit (loss) for the period before taxes | 9903 | €239,624 | €231,624 | -€8,000 | -3.3% |
| Income taxes | 67/77 | €73,436 | €75,656 | +€2,220 | +3.0% |
| Profit (loss) for the period | 9904 | €166,188 | €155,968 | -€10,220 | -6.1% |
| Profit (loss) for the period to be appropriated | 9905 | €166,188 | €155,968 | -€10,220 | -6.1% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.